Jane, a patient with chest pain and a family history of heart attacks, was struggling with obesity. She had tried various methods to lose weight but had heard about a drug called Ozempic that could help. However, her insurance denied coverage. Compounded versions of Ozempic became available online, but these drugs were not regulated and posed significant risks to patients. Despite the challenges, Jane and her doctor decided to try a different medication for weight loss. The issue highlighted the need for better regulation of compounded drugs and more affordable options for patients like Jane.
Source link
Online compounded semaglutide comes with serious risks
